In patients with heart failure, a decrease in effective blood volume and atrial filling is sensed by the left atrial baroreceptors, resulting in stimulation of vasopressin secretion and the consequent increases AQP2 expression and trafficking to the apical membrane of principal cells of the collecting duct. The gene discussed is AQP2; the disease is heart failure.